Home About us Articles Multimedia Search Instructions Login 
5 years IF: 1.036 (® Thomson Reuters)
IF 2016: 1.064 (® Thomson Reuters)
Total Cites: 7140
Follow Us
Follow Us
  • Users Online: 2007
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial

Mao Ying, Yao Yu, Zhang Li-Wei, Lu Yi-Cheng, Chen Zhong-Ping, Zhang Jian-Min, Qi Song-Tao, You Chao, Wang Ren-Zhi, Yang Shu-Yuan, Zhang Xiang, Wang Ji-Sheng, Chen Ju-Xiang, Yang Qun-Ying, Shen Hong, Li Zhi-Yong, Wang Xiang, Ma Wen-Bin, Yang Xue-Jun, Zhen Hai-Ning, Zhou Liang-Fu

Year : 2015| Volume: 128| Issue : 20 | Page no: 2751-2758

   This article has been cited by
1 Intracranial AAV-IFN-▀ gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model
Dwijit GuhaSarkar,James Neiswender,Qin Su,Guangping Gao,Miguel Sena-Esteves
Molecular Oncology. 2017;
[Pubmed]  [Google Scholar] [DOI]
2 Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial
Annika Malmstr÷m,Hans Skovgaard Poulsen,Bj°rn Henning Gr°nberg,Giuseppe Stragliotto,Steinbj°rn Hansen,Thomas Asklund,Birgitta Holmlund,Malgorzata Lysiak,Joseph Dowsett,Bjarne Winther Kristensen,Peter S÷derkvist,Johan Rosell,Roger Henriksson
Acta Oncologica. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]


Read this article